CRON Q4 2023 Earnings — Cronos Group Inc. Revenue & Financial Results | Market Cap Arena

CRONCronos Group Inc.

$983M

Q4 2023 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$24M+4.5% YoY

Gross Profit

$2M8.0% margin

Operating Income

-$22M-90.5% margin

Net Income

-$45M-187.3% margin

EPS (Diluted)

$-0.12

QoQ Revenue Growth

-3.6%

Cash Flow

Operating Cash Flow

$17M

Free Cash Flow

$15M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$44M

Stockholders' Equity

$1.1B

Cash & Equivalents

$669M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$24M	$23M	+4.5%
Gross Profit	$2M	-$234,000	+917.5%
Operating Income	-$22M	-$37M	+40.9%
Net Income	-$45M	-$79M	+43.2%

Revenue Segments

Cannabis Flower

$18M75%

Cannabis Extracts

$5M23%

Product and Service, Other

$327,0001%

Geographic Segments

CANADA

$18M75%

ISRAEL

$5M21%

Other Countries

$1M4%